Technical Analysis for SHPH - Shuttle Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
F 2.03 -16.12% -0.39
SHPH closed down 16.12 percent on Thursday, January 26, 2023, on 21 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
MACD Bullish Centerline Cross Bullish -16.12%
Inside Day Range Contraction -16.12%
Wide Bands Range Expansion -16.12%
Upper Bollinger Band Touch Strength -16.12%
Pocket Pivot Bullish Swing Setup -17.81%
Wide Bands Range Expansion -17.81%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below 50 DMA about 8 hours ago
50 DMA Support about 9 hours ago
Down 1 ATR about 9 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Fell Below 10 DMA about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Radiation Radiation Therapy Sarcoma Brain Tumor Liver Cancer Soft Tissue Sarcoma

Is SHPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 126.26
52 Week Low 1.35
Average Volume 1,825,433
200-Day Moving Average 0.00
50-Day Moving Average 2.07
20-Day Moving Average 2.00
10-Day Moving Average 2.19
Average True Range 0.34
RSI 46.81
ADX 24.12
+DI 28.24
-DI 16.33
Chandelier Exit (Long, 3 ATRs) 1.84
Chandelier Exit (Short, 3 ATRs) 2.62
Upper Bollinger Bands 2.48
Lower Bollinger Band 1.51
Percent B (%b) 0.53
BandWidth 48.72
MACD Line 0.00
MACD Signal Line -0.06
MACD Histogram 0.0604
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.59
Resistance 3 (R3) 2.65 2.53 2.50
Resistance 2 (R2) 2.53 2.38 2.50 2.47
Resistance 1 (R1) 2.28 2.29 2.21 2.22 2.44
Pivot Point 2.15 2.15 2.12 2.12 2.15
Support 1 (S1) 1.90 2.01 1.84 1.84 1.62
Support 2 (S2) 1.77 1.92 1.74 1.59
Support 3 (S3) 1.52 1.77 1.56
Support 4 (S4) 1.47